Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

被引：0
作者：
François-Clément Bidard
David Hajage
Thomas Bachelot
Suzette Delaloge
Etienne Brain
Mario Campone
Paul Cottu
Philippe Beuzeboc
Emilie Rolland
Claire Mathiot
Jean-Yves Pierga
机构：
[1] Institut Curie,Department of Medical Oncology
[2] Université Paris Descartes,Department of Biostatistics
[3] Institut Curie,Department of Medical Oncology
[4] Centre Léon Bérard,Department of Medical Oncology
[5] Institut Gustave Roussy,Department of Medical Oncology
[6] Institut Curie,Department of Medical Oncology
[7] Hôpital René Huguenin,Hematology laboratory
[8] Institut de Cancérologie de l'Ouest,undefined
[9] Bd Monod,undefined
[10] Institut Curie,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Progression Free Survival; Metastatic Breast Cancer; Circulate Tumor Cell; Serum Marker; Metastatic Breast Cancer Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies
    Francisco J Esteva
    Carol D Cheli
    Herbert Fritsche
    Monica Fornier
    Dennis Slamon
    Robert P Thiel
    Diana Luftner
    Farooq Ghani
    Breast Cancer Research, 7
  • [22] Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
    Bahriye Aktas
    Mitra Tewes
    Tanja Fehm
    Siegfried Hauch
    Rainer Kimmig
    Sabine Kasimir-Bauer
    Breast Cancer Research, 11
  • [23] Circulating tumor cells in metastatic inflammatory breast cancer
    Mego, M.
    De Giorgi, U.
    Hsu, L.
    Ueno, N. T.
    Valero, V.
    Jackson, S.
    Andreopoulou, E.
    Kau, S. -W.
    Reuben, J. M.
    Cristofanilli, M.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1824 - 1828
  • [24] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [25] Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer
    Gill, S.
    Berry, S.
    Biagi, J.
    Butts, C.
    Buyse, M.
    Chen, E.
    Jonker, D.
    Marginean, C.
    Samson, B.
    Stewart, J.
    Thirlwell, M.
    Wong, R.
    Maroun, J. A.
    CURRENT ONCOLOGY, 2011, 18 : S5 - S10
  • [26] Circulating tumor and endothelial cells as predictors of response in metastatic breast cancer
    M Cristofanilli
    Breast Cancer Research, 9
  • [27] The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
    Wallwiener, Markus
    Hartkopf, Andreas Daniel
    Baccelli, Irene
    Riethdorf, Sabine
    Schott, Sarah
    Pantel, Klaus
    Marme, Frederik
    Sohn, Christof
    Trumpp, Andreas
    Rack, Brigitte
    Aktas, Bahriye
    Solomayer, Erich-Franz
    Mueller, Volkmar
    Janni, Wolfgang
    Schneeweiss, Andreas
    Fehm, Tanja Natascha
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 503 - 510
  • [28] Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients
    Vermaat, Joost S.
    Gerritse, Frank L.
    van der Veldt, Astrid A.
    Roessingh, Wijnand M.
    Niers, Tatjana M.
    Oosting, Sjoukje F.
    Sleijfer, Stefan
    Roodhart, Jeanine M.
    Beijnen, Jos H.
    Schellens, Jan H.
    Gietema, Jourik A.
    Boven, Epie
    Richel, Dick J.
    Haanen, John B.
    Voest, Emile E.
    EUROPEAN UROLOGY, 2012, 62 (04) : 685 - 695
  • [29] The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
    Markus Wallwiener
    Andreas Daniel Hartkopf
    Irène Baccelli
    Sabine Riethdorf
    Sarah Schott
    Klaus Pantel
    Frederik Marmé
    Christof Sohn
    Andreas Trumpp
    Brigitte Rack
    Bahriye Aktas
    Erich-Franz Solomayer
    Volkmar Müller
    Wolfgang Janni
    Andreas Schneeweiss
    Tanja Natascha Fehm
    Breast Cancer Research and Treatment, 2013, 137 : 503 - 510
  • [30] Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
    Volkmar Müller
    Sabine Riethdorf
    Brigitte Rack
    Wolfgang Janni
    Peter A Fasching
    Erich Solomayer
    Bahriye Aktas
    Sabine Kasimir-Bauer
    Julia Zeitz
    Klaus Pantel
    Tanja Fehm
    Breast Cancer Research, 13
12345